El­bow is­sue ends Sale’s sea­son

The Morning Call - - SPORTS -

BOS­TON — Red Sox left-han­der Chris Sale is re­ceiv­ing treat­ment for inflammati­on in his el­bow that will shut him down for the rest of the reg­u­lar sea­son, an­other blow to the de­fend­ing World Se­ries cham­pi­ons whose post­sea­son hopes ap­pear all but dashed.

Ortho­pe­dist Dr. James An­drews gave Sale an in­jec­tion of platelet-rich plasma Mon­day and said he will be re-eval­u­ated in six weeks.

Look­ing be­yond this frus­trat­ing sea­son, the treat­ment could be good news for the club, which feared Sale might need Tommy John surgery. That would likely have cost him the 2020 sea­son.

The Red Sox were off Mon­day and en­tered the day 61⁄2 games out of a wild-card spot.

The 30-year-old Sale was com­ing off two solid starts in which he combined for 25 strike­outs — in­clud­ing the 2,000th of his ca­reer — and al­lowed only three runs in 142⁄3 in­nings.

Sale fin­ished the sea­son 6-11 with a 4.40 ERA in 25 starts and 1471⁄3 in­nings.

Sale, a seven-time All-Star in his 10th sea­son, was the fastest to reach 2,000 strike­outs in ma­jor league his­tory.

Last sea­son, Sale dealt with shoul­der sore­ness af­ter the All-Star break, lim­it­ing him to 29 in­nings.

He was also limited in the post­sea­son, but closed out the World Se­ries by strik­ing out then-Dodgers in­fielder Manny Machado to clinch the Red Sox’s fourth ti­tle in 15 seasons.

Sale signed a six-year, $160 mil­lion con­tract in March that in­cludes $50 mil­lion in de­ferred money.


The Red Sox shut down ace Chris Sale, but he won’t need Tommy John surgery.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.